ProKidney focuses on cell therapy for chronic kidney diseases, with REACT in Phase 3 trials and FDA's RMAT designation. Financially stable, with $446M in liquid assets and a 37-month cash runway, but ...

ProKidney (NASDAQ:PROK) said Monday that it has appointed a new CEO and plans to update its Phase 3 development program for its cell therapy REACT to focus on patients with advanced chronic kidney ...

SEATTLE — On Wednesday afternoon, President Donald Trump announced via Truth Social that a first-phase peace deal has been agreed upon by Israel and Hamas, and local leaders within Seattle are ...

(Reuters) -U.S. President Donald Trump said on Wednesday that Israel and Hamas had reached a long-sought deal for a Gaza ceasefire and hostage release under his plan for ending the two-year-old war in ...

MISSION OF FREEING THE HOSTAGES. TONIGHT, A MAJOR BREAKTHROUGH IN THE WAR IN THE MIDDLE EAST. ISRAEL AND HAMAS, BOTH AGREEING TO THE FIRST PHASE OF A PEACE DEAL, WHICH WOULD PUT A PAUSE ON FIGHTING IN ...

Israeli troops are withdrawing from Gaza as the first phase of a peace deal to end the war with Hamas begins, the military says. The ceasefire agreement came into effect at midnight on Thursday, ...